BharatTax.net
SearchITATHigh CourtsSupreme CourtPhrasesAI ResearchHistory

Filters

BharatTax.net

Free search engine for ITAT (Income Tax Appellate Tribunal) judgments across all 28 benches in India.

Quick Links

  • Search Judgments
  • Browse by Bench
  • Recent Judgments

About

BharatTax provides free access to Income Tax Appellate Tribunal orders for legal research and reference.

© 2026 BharatTax.net. All rights reserved.

17 results for “section 68”+ Section 144C(13)clear

Sorted by relevance

Mumbai742Delhi616Bangalore278Ahmedabad88Hyderabad69Pune68Kolkata63Chennai46Jaipur18Chandigarh17Dehradun17Indore14Surat8Cuttack6Rajkot6Visakhapatnam5Karnataka4Cochin3Raipur2SC2Amritsar2Jodhpur1Telangana1Guwahati1

Key Topics

Section 1487Addition to Income5Section 1474Section 50C3Section 683Section 2343Section 144C3Reopening of Assessment3Undisclosed Income3

DCIT, C-1(1) , CHANDIGARH vs. M/S FIDELITY INFORMATION SERVICES INDIA PVT. LTD., CHANDIGARH

In the result, the cross-objection filed by the assessee is dismissed

ITA 1328/CHANDI/2019[2014-15]Status: DisposedITAT Chandigarh07 Jun 2024AY 2014-15

Bench: SHRI. AAKASH DEEP JAIN (Vice President), SHRI. VIKRAM SINGH YADAV (Accountant Member)

For Appellant: Shri Vishal Kalra, Advocate and Ms. Sumisha, C.AFor Respondent: Shri Rohit Sharma, CIT DR
Section 37(1)

144C(13) r.w.s. 143(3) dated 31.10.2012 & for A.Y. 2008-09, that the AO has held that the assessee had failed to show how the inclusion of the expenses was done in the cost charged by the assessee company to its client. Further, the AO held that the assessee failed to explain how these expenses related to the normal business

M/S JOSAN INDUSTRIES,JALALABAD vs. DCIT, CL-1, INTL. TAXATION, CHANDIGARH

In the result, the appeal is partly allowed as indicated

Section 37(1)2
ITA 65/CHANDI/2023[2014-15]Status: DisposedITAT Chandigarh19 Mar 2024AY 2014-15

Bench: Shri A.D. Jain & Shri Vikram Singh Yadavआयकर अपील सं./ Ita Nos. 64 To 66/Chd/2023 "नधा"रण वष" / Assessment Years : 2013-14, 2014-15 & 2015-16 Josan Industries, Vs. The Dcit Circle-1, बनाम Jalalabad, International Taxation, H.O., Guruharshai, Chandigarh Punjab "थायी लेखा सं./Pan No. Aaafj7294F अपीलाथ"/Appellant ""यथ"/Respondent

For Appellant: Shri Tej Mohan Singh, AdvocateFor Respondent: Shri J.S. Kahlon, CIT DR
Section 144CSection 147Section 148Section 234Section 68

13) has exceeded the jurisdiction in as much 64 to 66-Chd-2023- – M//s Josan Industries, Jalalabad 2 the residential status of assessee firm is admittedly "Resident" as per the impugned order passed and not "NRI" as mentioned in the body of the impugned order and as such the order passed is illegal, arbitrary and unjustified. 2. That since

M/S JOSAN INDUSTRIES,JALALABAD vs. DCIT, CL-1, INTL. TAXATION, CHANDIGARH

In the result, the appeal is partly allowed as indicated

ITA 64/CHANDI/2023[2013-14]Status: DisposedITAT Chandigarh19 Mar 2024AY 2013-14

Bench: Shri A.D. Jain & Shri Vikram Singh Yadavआयकर अपील सं./ Ita Nos. 64 To 66/Chd/2023 "नधा"रण वष" / Assessment Years : 2013-14, 2014-15 & 2015-16 Josan Industries, Vs. The Dcit Circle-1, बनाम Jalalabad, International Taxation, H.O., Guruharshai, Chandigarh Punjab "थायी लेखा सं./Pan No. Aaafj7294F अपीलाथ"/Appellant ""यथ"/Respondent

For Appellant: Shri Tej Mohan Singh, AdvocateFor Respondent: Shri J.S. Kahlon, CIT DR
Section 144CSection 147Section 148Section 234Section 68

13) has exceeded the jurisdiction in as much 64 to 66-Chd-2023- – M//s Josan Industries, Jalalabad 2 the residential status of assessee firm is admittedly "Resident" as per the impugned order passed and not "NRI" as mentioned in the body of the impugned order and as such the order passed is illegal, arbitrary and unjustified. 2. That since

M/S JOSAN INDUSTRIES,JALALABAD vs. DCIT, CL-1, INTL. TAXATION, CHANDIGARH

In the result, the appeal is partly allowed as indicated

ITA 66/CHANDI/2023[2015-16]Status: DisposedITAT Chandigarh19 Mar 2024AY 2015-16

Bench: Shri A.D. Jain & Shri Vikram Singh Yadavआयकर अपील सं./ Ita Nos. 64 To 66/Chd/2023 "नधा"रण वष" / Assessment Years : 2013-14, 2014-15 & 2015-16 Josan Industries, Vs. The Dcit Circle-1, बनाम Jalalabad, International Taxation, H.O., Guruharshai, Chandigarh Punjab "थायी लेखा सं./Pan No. Aaafj7294F अपीलाथ"/Appellant ""यथ"/Respondent

For Appellant: Shri Tej Mohan Singh, AdvocateFor Respondent: Shri J.S. Kahlon, CIT DR
Section 144CSection 147Section 148Section 234Section 68

13) has exceeded the jurisdiction in as much 64 to 66-Chd-2023- – M//s Josan Industries, Jalalabad 2 the residential status of assessee firm is admittedly "Resident" as per the impugned order passed and not "NRI" as mentioned in the body of the impugned order and as such the order passed is illegal, arbitrary and unjustified. 2. That since

NEERU ARORA,CHANDIGARH vs. CIRCLE-1, INTERNATIONAL TAXATION, CHANDIGARH

In the result, the appeal of the assessee is partly allowed in terms indicated above

ITA 60/CHANDI/2024[2013-14]Status: DisposedITAT Chandigarh25 Jun 2025AY 2013-14

Bench: SHRI. LALIET KUMAR (Judicial Member), SHRI. MANOJ KUMAR AGGARWAL (Accountant Member)

For Appellant: Shri Parikshit Aggarwal, C.AFor Respondent: Smt. Tarundeep Kaur, CIT, DR
Section 142(1)Section 144C(2)Section 147Section 148Section 2(47)(v)Section 48Section 50CSection 50C(1)Section 50C(2)Section 53A

144C(2) on 31.03.2023, along with Form No. 35A and various annexures, challenging the year of taxability, the incorrect application of section 50C, and the denial of deduction for the cost of acquisition. 8. The assessee contended that the transfer of the capital asset was completed in A.Y. 2010-11 when possession was handed over and full consideration

ACIT, CHANDIGARH vs. M/S GLAXO SMITHKLINE ASIA PVT. LTD., GURGAON

In the result, all the appeals of the assessee and the Revenue, stand partly allowed for statistical purposes

ITA 221/CHANDI/2017[2009-10]Status: DisposedITAT Chandigarh26 Oct 2021AY 2009-10

13 Wockhardt Ltd. 9.2% 14 Tyche Industries Ltd. 10.19% 15 Granules India Ltd 13.49% 16 NGL Fine Chem Ltd. 14.04% 17 Hikal Limited- Pharma Segment 18.05% 18 Shilpa Medicare Limited 23.27% 19 IOL Chemicals and Pharmaceuticals 25.03 Limited-Bulk Drugs Segment 20 Kothari Phytochemicals & Inds.Ltd.- Bulk 31.42% Drugs segment 21 Harman Finochem Ltd. 38.43% 22 Suven Life Sciences Ltd.- Manufacturing

ACIT, CHANDIGARH vs. M/S GLAXO SMITHKLINE ASIA PVT. LTD., GURGAON

In the result, all the appeals of the assessee and the Revenue, stand partly allowed for statistical purposes

ITA 222/CHANDI/2017[2009-10]Status: DisposedITAT Chandigarh26 Oct 2021AY 2009-10

13 Wockhardt Ltd. 9.2% 14 Tyche Industries Ltd. 10.19% 15 Granules India Ltd 13.49% 16 NGL Fine Chem Ltd. 14.04% 17 Hikal Limited- Pharma Segment 18.05% 18 Shilpa Medicare Limited 23.27% 19 IOL Chemicals and Pharmaceuticals 25.03 Limited-Bulk Drugs Segment 20 Kothari Phytochemicals & Inds.Ltd.- Bulk 31.42% Drugs segment 21 Harman Finochem Ltd. 38.43% 22 Suven Life Sciences Ltd.- Manufacturing

GLAXOSMITHKLINE ASIA PVT. LTD.,GURGAON vs. ACIT, CHANDIGARH

In the result, all the appeals of the assessee and the Revenue, stand partly allowed for statistical purposes

ITA 225/CHANDI/2017[2008-09]Status: DisposedITAT Chandigarh26 Oct 2021AY 2008-09

13 Wockhardt Ltd. 9.2% 14 Tyche Industries Ltd. 10.19% 15 Granules India Ltd 13.49% 16 NGL Fine Chem Ltd. 14.04% 17 Hikal Limited- Pharma Segment 18.05% 18 Shilpa Medicare Limited 23.27% 19 IOL Chemicals and Pharmaceuticals 25.03 Limited-Bulk Drugs Segment 20 Kothari Phytochemicals & Inds.Ltd.- Bulk 31.42% Drugs segment 21 Harman Finochem Ltd. 38.43% 22 Suven Life Sciences Ltd.- Manufacturing

GLAXOSMITHKLINE ASIA PVT. LTD.,GURGAON vs. ACIT, CHANDIGARH

In the result, all the appeals of the assessee and the Revenue, stand partly allowed for statistical purposes

ITA 226/CHANDI/2017[2009-10]Status: DisposedITAT Chandigarh26 Oct 2021AY 2009-10

13 Wockhardt Ltd. 9.2% 14 Tyche Industries Ltd. 10.19% 15 Granules India Ltd 13.49% 16 NGL Fine Chem Ltd. 14.04% 17 Hikal Limited- Pharma Segment 18.05% 18 Shilpa Medicare Limited 23.27% 19 IOL Chemicals and Pharmaceuticals 25.03 Limited-Bulk Drugs Segment 20 Kothari Phytochemicals & Inds.Ltd.- Bulk 31.42% Drugs segment 21 Harman Finochem Ltd. 38.43% 22 Suven Life Sciences Ltd.- Manufacturing

GLAXOSMITHKLINE ASIA PVT. LTD.,GURGAON vs. DCIT, CHANDIGARH

In the result, all the appeals of the assessee and the Revenue, stand partly allowed for statistical purposes

ITA 227/CHANDI/2017[2010-11]Status: DisposedITAT Chandigarh26 Oct 2021AY 2010-11

13 Wockhardt Ltd. 9.2% 14 Tyche Industries Ltd. 10.19% 15 Granules India Ltd 13.49% 16 NGL Fine Chem Ltd. 14.04% 17 Hikal Limited- Pharma Segment 18.05% 18 Shilpa Medicare Limited 23.27% 19 IOL Chemicals and Pharmaceuticals 25.03 Limited-Bulk Drugs Segment 20 Kothari Phytochemicals & Inds.Ltd.- Bulk 31.42% Drugs segment 21 Harman Finochem Ltd. 38.43% 22 Suven Life Sciences Ltd.- Manufacturing

GLAXOSMITHKLINE ASIA PVT. LTD.,GURGAON vs. DCIT, CHANDIGARH

In the result, all the appeals of the assessee and the Revenue, stand partly allowed for statistical purposes

ITA 228/CHANDI/2017[2011-12]Status: DisposedITAT Chandigarh26 Oct 2021AY 2011-12

13 Wockhardt Ltd. 9.2% 14 Tyche Industries Ltd. 10.19% 15 Granules India Ltd 13.49% 16 NGL Fine Chem Ltd. 14.04% 17 Hikal Limited- Pharma Segment 18.05% 18 Shilpa Medicare Limited 23.27% 19 IOL Chemicals and Pharmaceuticals 25.03 Limited-Bulk Drugs Segment 20 Kothari Phytochemicals & Inds.Ltd.- Bulk 31.42% Drugs segment 21 Harman Finochem Ltd. 38.43% 22 Suven Life Sciences Ltd.- Manufacturing

M/S GLAXOSMITHKLINE ASIA PVT. LTD.,GURGAON vs. ACIT, CHANDIGARH

In the result, all the appeals of the assessee and the Revenue, stand partly allowed for statistical purposes

ITA 242/CHANDI/2017[2007-08]Status: DisposedITAT Chandigarh26 Oct 2021AY 2007-08

13 Wockhardt Ltd. 9.2% 14 Tyche Industries Ltd. 10.19% 15 Granules India Ltd 13.49% 16 NGL Fine Chem Ltd. 14.04% 17 Hikal Limited- Pharma Segment 18.05% 18 Shilpa Medicare Limited 23.27% 19 IOL Chemicals and Pharmaceuticals 25.03 Limited-Bulk Drugs Segment 20 Kothari Phytochemicals & Inds.Ltd.- Bulk 31.42% Drugs segment 21 Harman Finochem Ltd. 38.43% 22 Suven Life Sciences Ltd.- Manufacturing

M/S GLAXO SMITHKLINE ASIA PVT. LTD.,GURGAON vs. ACIT, C-4(1), CHANDIGARH

In the result, all the appeals of the assessee and the Revenue, stand partly allowed for statistical purposes

ITA 1500/CHANDI/2018[2014-15]Status: DisposedITAT Chandigarh26 Oct 2021AY 2014-15

13 Wockhardt Ltd. 9.2% 14 Tyche Industries Ltd. 10.19% 15 Granules India Ltd 13.49% 16 NGL Fine Chem Ltd. 14.04% 17 Hikal Limited- Pharma Segment 18.05% 18 Shilpa Medicare Limited 23.27% 19 IOL Chemicals and Pharmaceuticals 25.03 Limited-Bulk Drugs Segment 20 Kothari Phytochemicals & Inds.Ltd.- Bulk 31.42% Drugs segment 21 Harman Finochem Ltd. 38.43% 22 Suven Life Sciences Ltd.- Manufacturing

M/S GLAXO SMITHKLINE ASIA PVT. LTD.,GURGAON vs. ACIT, C-4(1), CHANDIGARH

In the result, all the appeals of the assessee and the Revenue, stand partly allowed for statistical purposes

ITA 47/CHANDI/2018[2013-14]Status: DisposedITAT Chandigarh26 Oct 2021AY 2013-14

13 Wockhardt Ltd. 9.2% 14 Tyche Industries Ltd. 10.19% 15 Granules India Ltd 13.49% 16 NGL Fine Chem Ltd. 14.04% 17 Hikal Limited- Pharma Segment 18.05% 18 Shilpa Medicare Limited 23.27% 19 IOL Chemicals and Pharmaceuticals 25.03 Limited-Bulk Drugs Segment 20 Kothari Phytochemicals & Inds.Ltd.- Bulk 31.42% Drugs segment 21 Harman Finochem Ltd. 38.43% 22 Suven Life Sciences Ltd.- Manufacturing

M/S GLAXO SMITHKLINE ASIA PVT. LTD.,NABHA vs. DCIT, C-4(1), CHANDIGARH

In the result, all the appeals of the assessee and the Revenue, stand partly allowed for statistical purposes

ITA 1495/CHANDI/2019[2015-16]Status: DisposedITAT Chandigarh26 Oct 2021AY 2015-16

13 Wockhardt Ltd. 9.2% 14 Tyche Industries Ltd. 10.19% 15 Granules India Ltd 13.49% 16 NGL Fine Chem Ltd. 14.04% 17 Hikal Limited- Pharma Segment 18.05% 18 Shilpa Medicare Limited 23.27% 19 IOL Chemicals and Pharmaceuticals 25.03 Limited-Bulk Drugs Segment 20 Kothari Phytochemicals & Inds.Ltd.- Bulk 31.42% Drugs segment 21 Harman Finochem Ltd. 38.43% 22 Suven Life Sciences Ltd.- Manufacturing

ACIT, CHANDIGARH vs. M/S GLAXO SMITHKLINE ASIA PVT. LTD., GURGAON

In the result, all the appeals of the assessee and the Revenue, stand partly allowed for statistical purposes

ITA 220/CHANDI/2017[2008-09]Status: DisposedITAT Chandigarh26 Oct 2021AY 2008-09

13 Wockhardt Ltd. 9.2% 14 Tyche Industries Ltd. 10.19% 15 Granules India Ltd 13.49% 16 NGL Fine Chem Ltd. 14.04% 17 Hikal Limited- Pharma Segment 18.05% 18 Shilpa Medicare Limited 23.27% 19 IOL Chemicals and Pharmaceuticals 25.03 Limited-Bulk Drugs Segment 20 Kothari Phytochemicals & Inds.Ltd.- Bulk 31.42% Drugs segment 21 Harman Finochem Ltd. 38.43% 22 Suven Life Sciences Ltd.- Manufacturing

ACIT, CHANDIGARH vs. M/S GLAXO SMITHKLINE ASIA PVT. LTD., GURGAON

In the result, all the appeals of the assessee and the Revenue, stand partly allowed for statistical purposes

ITA 219/CHANDI/2017[2007-08]Status: DisposedITAT Chandigarh26 Oct 2021AY 2007-08

13 Wockhardt Ltd. 9.2% 14 Tyche Industries Ltd. 10.19% 15 Granules India Ltd 13.49% 16 NGL Fine Chem Ltd. 14.04% 17 Hikal Limited- Pharma Segment 18.05% 18 Shilpa Medicare Limited 23.27% 19 IOL Chemicals and Pharmaceuticals 25.03 Limited-Bulk Drugs Segment 20 Kothari Phytochemicals & Inds.Ltd.- Bulk 31.42% Drugs segment 21 Harman Finochem Ltd. 38.43% 22 Suven Life Sciences Ltd.- Manufacturing